CIK: 0001703031
Total reported value
$1.1B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | DRNAUSD | Dicerna Pharmaceuticals INC | Stock-Other | 30.93% | — | — | |
| 2 | SLDB | Solid Biosciences Inc. | Stock-Other | 21.30% | — | — | |
| 3 | ✓ | Aptinyx INC | Stock-Other | 14.62% | — | — | |
| 4 | IFRX | InflaRx N.V. | Stock-Other | 13.75% | — | -0.07% | |
| 5 | REPL | Replimune Group INC | Stock-Other | 10.37% | — | — | |
| 6 | MRNSUSD | Marinus Pharmaceuticals INC | Stock-Other | 9.03% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | MRNSUSD | Marinus Pharmaceuticals INC | +0.2% | — | Unchanged |
| 2 | SLDB | Solid Biosciences Inc. | -0.9% | — | Unchanged |
| 3 | ✓ | Aptinyx INC | -2.2% | — | Unchanged |
| 4 | DRNAUSD | Dicerna Pharmaceuticals INC | -3.4% | — | Unchanged |
| 5 | IFRX | InflaRx N.V. | -4.1% | -0.07% | Trim |
| 6 | REPL | Replimune Group INC | — | NEW | New buy |